Orbimed Advisors Llc - Net Worth and Insider Trading

Orbimed Advisors Llc Net Worth

The estimated net worth of Orbimed Advisors Llc is at least $3.5 Billion dollars as of 2024-04-27. Orbimed Advisors Llc is the Director, 10% Owner of Synthorx Inc and owns about 5,316,355 shares of Synthorx Inc (THOR) stock worth over $361 Million. Orbimed Advisors Llc is the Director, 10% Owner of Prevail Therapeutics Inc and owns about 13,822,463 shares of Prevail Therapeutics Inc (PRVL) stock worth over $318 Million. Orbimed Advisors Llc is also the 10% Owner of SpringWorks Therapeutics Inc and owns about 5,599,842 shares of SpringWorks Therapeutics Inc (SWTX) stock worth over $255 Million. Besides these, Orbimed Advisors Llc also holds Edgewise Therapeutics Inc (EWTX) , Loxo Oncology Inc (LOXO) , Audentes Therapeutics Inc (BOLD) , Principia Biopharma Inc (PRNB) , Turning Point Therapeutics Inc (TPTX) , Relypsa Inc (RLYP) , Rhythm Pharmaceuticals Inc (RYTM) , Supernus Pharmaceuticals Inc (SUPN) , NxStage Medical Inc (NXTM) , ARS Pharmaceuticals Inc (SPRY) , Theseus Pharmaceuticals Inc (THRX) , Mirati Therapeutics Inc (MRTX) , CTI BioPharma Corp (CTIC) , Fusion Pharmaceuticals Inc (FUSN) , Keros Therapeutics Inc (KROS) , Pacira BioSciences Inc (PCRX) , Third Harmonic Bio Inc (THRD) , Verona Pharma PLC (VRNA) , Intellia Therapeutics Inc (NTLA) , Silverback Therapeutics Inc (SBTX) , NeuroPace Inc (NPCE) , Prelude Therapeutics Inc (PRLD) , Terns Pharmaceuticals Inc (TERN) , Dimension Therapeutics Inc (DMTX) , Compass Therapeutics Inc (CMPX) , Imara Inc (IMRA) , scPharmaceuticals Inc (SCPH) , ArriVent BioPharma Inc (AVBP) , CalciMedica Inc (CALC) , Intercept Pharmaceuticals Inc (ICPT) , Adicet Bio Inc (ACET) , ORIC Pharmaceuticals Inc (ORIC) , Alpine Immune Sciences Inc (ALPN) , 89bio Inc (ETNB) , SI-BONE Inc (SIBN) , Constellation Pharmaceuticals Inc (CNST) , TELA Bio Inc (TELA) , PMV Pharmaceuticals Inc (PMVP) , Janux Therapeutics Inc (JANX) , Passage Bio Inc (PASG) , Corvus Pharmaceuticals Inc (CRVS) , Alector Inc (ALEC) , Turnstone Biologics Corp (TSBX) , Disc Medicine Inc (IRON) , Adaptimmune Therapeutics PLC (ADAP) , Decibel Therapeutics Inc (DBTX) , NextCure Inc (NXTC) , Arcutis Biotherapeutics Inc (ARQT) , Xtant Medical Holdings Inc (XTNT) , Spyre Therapeutics Inc (SYRE) , resTORbio Inc (TORC) , Cartesian Therapeutics Inc (RNAC) , Kinnate Biopharma Inc (KNTE) , Acutus Medical Inc (AFIB) , Galecto Inc (GLTO) , Aerpio Pharmaceuticals Inc (ARPO) , LogicBio Therapeutics Inc (LOGC) , Kala Bio Inc (KALA) , Inspire Medical Systems Inc (INSP) , Repare Therapeutics Inc (RPTX) , Ikena Oncology Inc (IKNA) , Sientra Inc (SIENQ) , Otonomy Inc (OTIC) , Pieris Pharmaceuticals Inc (PIRS) , ViewRay Inc (VRAYQ) , Logic Devices Inc (LOGC) , Athersys Inc (ATHXQ) , Sorrento Tech Inc (ROKA) , SteadyMed Ltd (STDY) , Glaukos Corp (GKOS) , Tricida Inc (TCDAQ) . Details can be seen in Orbimed Advisors Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Orbimed Advisors Llc has not made any transactions after 2024-04-24 and currently still holds the listed stock(s).

Transaction Summary of Orbimed Advisors Llc

To

Orbimed Advisors Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Orbimed Advisors Llc owns 92 companies in total, including Arcutis Biotherapeutics Inc (ARQT) , Xtant Medical Holdings Inc (XTNT) , and LogicBio Therapeutics Inc (LOGC) among others .

Click here to see the complete history of Orbimed Advisors Llc’s form 4 insider trades.

Insider Ownership Summary of Orbimed Advisors Llc

Ticker Comapny Transaction Date Type of Owner
ARQT Arcutis Biotherapeutics Inc 2022-06-24 director & 10 percent owner
XTNT Xtant Medical Holdings Inc 2018-02-14 10 percent owner
LOGC LogicBio Therapeutics Inc 2020-10-01 director & 10 percent owner
CALC CalciMedica Inc 2020-09-25 director & 10 percent owner
PRLD Prelude Therapeutics Inc 2023-05-22 director & 10 percent owner
PMVP PMV Pharmaceuticals Inc 2023-11-22 10 percent owner
ETNB 89bio Inc 2022-01-26 director & 10 percent owner
INSP Inspire Medical Systems Inc 2020-08-18 director
AFIB Acutus Medical Inc 2021-07-19 director & 10 percent owner
PAND Pandion Therapeutics Inc 2020-07-16 10 percent owner
FUSN Fusion Pharmaceuticals Inc 2020-06-30 director
RPTX Repare Therapeutics Inc 2021-09-07 director
SCPH scPharmaceuticals Inc 2022-11-25 10 percent owner
ORIC ORIC Pharmaceuticals Inc 2021-03-30 director
ALEC Alector Inc 2020-04-16 10 percent owner
KROS Keros Therapeutics Inc 2020-04-13 director
IMRA Imara Inc 2021-07-16 director & 10 percent owner
CTIC CTI BioPharma Corp 2021-01-07 10 percent owner
PASG Passage Bio Inc 2023-06-28 10 percent owner
SRRA Sierra Oncology Inc 2019-11-22 director & 10 percent owner
TCDAQ Tricida Inc 2022-11-25 director & 10 percent owner
TELA TELA Bio Inc 2023-04-21 10 percent owner
SWTX SpringWorks Therapeutics Inc 2022-09-12 10 percent owner
CRVS Corvus Pharmaceuticals Inc 2021-09-20 director
PRVL Prevail Therapeutics Inc 2019-06-24 director & 10 percent owner
PRNB Principia Biopharma Inc 2019-05-21 10 percent owner
NXTC NextCure Inc 2019-05-13 director & 10 percent owner
TPTX Turning Point Therapeutics Inc 2019-04-22 director
AVDR Avedro Inc 2019-02-19 10 percent owner
ALPN Alpine Immune Sciences Inc 2023-12-28 director
THOR Synthorx Inc 2018-12-11 director & 10 percent owner
SIBN SI-BONE Inc 2018-10-19 director
GH Guardant Health Inc 2018-10-03 10 percent owner
ARVN Arvinas Inc 2018-09-26 10 percent owner
STDY SteadyMed Ltd 2018-08-30 10 percent owner
VRAYQ ViewRay Inc 2018-08-20 director & 10 percent owner
CNST Constellation Pharmaceuticals Inc 2018-07-23 10 percent owner
CRNX Crinetics Pharmaceuticals Inc 2018-07-17 10 percent owner
ARPO Aerpio Pharmaceuticals Inc 2020-12-08 director & 10 percent owner
ARMO ARMO BioSciences Inc 2018-06-22 director & 10 percent owner
ADAP Adaptimmune Therapeutics PLC 2018-06-06 director
RYTM Rhythm Pharmaceuticals Inc 2018-05-22 10 percent owner
PIRS Pieris Pharmaceuticals Inc 2018-04-30 director & 10 percent owner
BOLD Audentes Therapeutics Inc 2018-03-12 10 percent owner
GKOS Glaukos Corp 2018-03-06 director
KALA Kala Bio Inc 2018-02-08 10 percent owner & other: See Remarks
SYBX Synlogic Inc 2017-08-28 director
LOXO Loxo Oncology Inc 2017-12-08 director
XFOR X4 Pharmaceuticals Inc 2017-11-15 10 percent owner
ROKA Sorrento Tech Inc 2017-10-03 10 percent owner
SYRE Spyre Therapeutics Inc 2017-02-21 10 percent owner
NBRVF Nabriva Therapeutics PLC 2016-12-30 director & 10 percent owner
RPBIF Response Biomedical Corp 2016-11-29 director & 10 percent owner
RLYP Relypsa Inc 2016-07-25 10 percent owner
RNAC Cartesian Therapeutics Inc 2016-06-27 director & 10 percent owner
NTLA Intellia Therapeutics Inc 2016-05-11 10 percent owner
OTIC Otonomy Inc 2015-11-30 director
DMTX Dimension Therapeutics Inc 2015-10-27 director & 10 percent owner
SIENQ Sientra Inc 2015-10-12 10 percent owner
ICPT Intercept Pharmaceuticals Inc 2015-03-26 director & 10 percent owner
MRTX Mirati Therapeutics Inc 2014-07-01 10 percent owner
XLRN Acceleron Pharma Inc 2013-09-24 other: Former 10% Owner
SUPN Supernus Pharmaceuticals Inc 2013-02-13 10 percent owner
ANTH Anthera Pharmaceuticals Inc 2013-01-30 director
AMRN Amarin Corp PLC 2011-01-01 director & 10 percent owner
PCRX Pacira BioSciences Inc 2012-03-12 10 percent owner
CCXI ChemoCentryx Inc 2012-02-08 10 percent owner
ATHXQ Athersys Inc 2011-04-26 director & other: (1)
NXTM NxStage Medical Inc 2010-12-09 director
KURU Kun Run Biotechnology Inc 2010-04-30 10 percent owner
ALBO Albireo Pharma Inc 2007-05-10 10 percent owner
ARYX ARYx Therapeutics Inc 2009-05-22 10 percent owner
PODD Insulet Corp 2007-05-14 director
AADI Aadi Bioscience Inc 2017-03-15 director & 10 percent owner
NPCE NeuroPace Inc 2024-04-23 10 percent owner
DBTX Decibel Therapeutics Inc 2021-02-17 10 percent owner
VRNA Verona Pharma PLC 2023-05-15 director & 10 percent owner
SBTX Silverback Therapeutics Inc 2020-12-08 director & 10 percent owner
EWTX Edgewise Therapeutics Inc 2024-01-23 director & 10 percent owner
ACET Adicet Bio Inc 2024-01-25 director & 10 percent owner
CMPX Compass Therapeutics Inc 2022-11-08 director & 10 percent owner
THRX Theseus Pharmaceuticals Inc 2023-07-17 director & 10 percent owner
KNTE Kinnate Biopharma Inc 2023-05-05 director
GLTO Galecto Inc 2023-08-15 director & 10 percent owner
IRON Disc Medicine Inc 2023-12-18 director & 10 percent owner
JANX Janux Therapeutics Inc 2021-12-29 director
TERN Terns Pharmaceuticals Inc 2022-12-23 director & 10 percent owner
IKNA Ikena Oncology Inc 2021-03-30 director
THRD Third Harmonic Bio Inc 2022-09-19 director & 10 percent owner
SPRY ARS Pharmaceuticals Inc 2023-08-29 director
ELVN Enliven Therapeutics Inc 2020-03-11 director & 10 percent owner
TSBX Turnstone Biologics Corp 2023-07-20 director & 10 percent owner

Orbimed Advisors Llc Latest Holdings Summary

Orbimed Advisors Llc currently owns a total of 74 stocks. Among these stocks, Orbimed Advisors Llc owns 5,316,355 shares of Synthorx Inc (THOR) as of December 11, 2018, with a value of $361 Million and a weighting of 10.25%. Orbimed Advisors Llc owns 13,822,463 shares of Prevail Therapeutics Inc (PRVL) as of June 24, 2019, with a value of $318 Million and a weighting of 9.01%. Orbimed Advisors Llc also owns 5,599,842 shares of SpringWorks Therapeutics Inc (SWTX) as of September 12, 2022, with a value of $255 Million and a weighting of 7.23%. The other 71 stocks Edgewise Therapeutics Inc (EWTX) , Loxo Oncology Inc (LOXO) , Audentes Therapeutics Inc (BOLD) , Principia Biopharma Inc (PRNB) , Turning Point Therapeutics Inc (TPTX) , Relypsa Inc (RLYP) , Rhythm Pharmaceuticals Inc (RYTM) , Supernus Pharmaceuticals Inc (SUPN) , NxStage Medical Inc (NXTM) , ARS Pharmaceuticals Inc (SPRY) , Theseus Pharmaceuticals Inc (THRX) , Mirati Therapeutics Inc (MRTX) , CTI BioPharma Corp (CTIC) , Fusion Pharmaceuticals Inc (FUSN) , Keros Therapeutics Inc (KROS) , Pacira BioSciences Inc (PCRX) , Third Harmonic Bio Inc (THRD) , Verona Pharma PLC (VRNA) , Intellia Therapeutics Inc (NTLA) , Silverback Therapeutics Inc (SBTX) , NeuroPace Inc (NPCE) , Prelude Therapeutics Inc (PRLD) , Terns Pharmaceuticals Inc (TERN) , Dimension Therapeutics Inc (DMTX) , Compass Therapeutics Inc (CMPX) , Imara Inc (IMRA) , scPharmaceuticals Inc (SCPH) , ArriVent BioPharma Inc (AVBP) , CalciMedica Inc (CALC) , Intercept Pharmaceuticals Inc (ICPT) , Adicet Bio Inc (ACET) , ORIC Pharmaceuticals Inc (ORIC) , Alpine Immune Sciences Inc (ALPN) , 89bio Inc (ETNB) , SI-BONE Inc (SIBN) , Constellation Pharmaceuticals Inc (CNST) , TELA Bio Inc (TELA) , PMV Pharmaceuticals Inc (PMVP) , Janux Therapeutics Inc (JANX) , Passage Bio Inc (PASG) , Corvus Pharmaceuticals Inc (CRVS) , Alector Inc (ALEC) , Turnstone Biologics Corp (TSBX) , Disc Medicine Inc (IRON) , Adaptimmune Therapeutics PLC (ADAP) , Decibel Therapeutics Inc (DBTX) , NextCure Inc (NXTC) , Arcutis Biotherapeutics Inc (ARQT) , Xtant Medical Holdings Inc (XTNT) , Spyre Therapeutics Inc (SYRE) , resTORbio Inc (TORC) , Cartesian Therapeutics Inc (RNAC) , Kinnate Biopharma Inc (KNTE) , Acutus Medical Inc (AFIB) , Galecto Inc (GLTO) , Aerpio Pharmaceuticals Inc (ARPO) , LogicBio Therapeutics Inc (LOGC) , Kala Bio Inc (KALA) , Inspire Medical Systems Inc (INSP) , Repare Therapeutics Inc (RPTX) , Ikena Oncology Inc (IKNA) , Sientra Inc (SIENQ) , Otonomy Inc (OTIC) , Pieris Pharmaceuticals Inc (PIRS) , ViewRay Inc (VRAYQ) , Logic Devices Inc (LOGC) , Athersys Inc (ATHXQ) , Sorrento Tech Inc (ROKA) , SteadyMed Ltd (STDY) , Glaukos Corp (GKOS) , Tricida Inc (TCDAQ) have a combined weighting of 73.52% among all his current holdings.

Latest Holdings of Orbimed Advisors Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
THOR Synthorx Inc 2018-12-11 5,316,355 67.99 361,458,976
PRVL Prevail Therapeutics Inc 2019-06-24 13,822,463 23.00 317,916,649
SWTX SpringWorks Therapeutics Inc 2022-09-12 5,599,842 45.53 254,960,806
EWTX Edgewise Therapeutics Inc 2024-01-23 14,756,096 16.17 238,606,072
LOXO Loxo Oncology Inc 2017-12-08 941,000 234.66 220,815,060
BOLD Audentes Therapeutics Inc 2018-03-12 3,539,997 59.97 212,293,620
PRNB Principia Biopharma Inc 2019-05-21 1,605,713 100.05 160,651,586
TPTX Turning Point Therapeutics Inc 2019-04-22 2,027,550 76.01 154,114,076
RLYP Relypsa Inc 2016-07-25 3,356,400 31.99 107,371,236
RYTM Rhythm Pharmaceuticals Inc 2018-05-22 2,750,079 38.28 105,273,024
SUPN Supernus Pharmaceuticals Inc 2013-02-13 3,000,000 30.07 90,210,000
NXTM NxStage Medical Inc 2010-12-09 2,690,476 30.00 80,714,280
SPRY ARS Pharmaceuticals Inc 2023-08-29 9,240,887 8.35 77,161,406
THRX Theseus Pharmaceuticals Inc 2023-07-17 17,713,600 4.06 71,917,216
MRTX Mirati Therapeutics Inc 2014-07-01 1,167,000 58.70 68,502,900
CTIC CTI BioPharma Corp 2021-01-07 7,520,600 9.09 68,362,254
FUSN Fusion Pharmaceuticals Inc 2020-06-30 3,122,770 21.42 66,889,733
KROS Keros Therapeutics Inc 2020-04-13 1,119,812 57.86 64,792,322
PCRX Pacira BioSciences Inc 2012-03-12 2,446,000 26.33 64,403,180
THRD Third Harmonic Bio Inc 2022-09-19 5,779,071 10.83 62,587,339
VRNA Verona Pharma PLC 2023-05-15 3,777,778 15.47 58,442,226
NTLA Intellia Therapeutics Inc 2016-05-11 2,662,180 20.76 55,266,857
SBTX Silverback Therapeutics Inc 2020-12-08 8,740,888 5.87 51,309,013
NPCE NeuroPace Inc 2024-04-24 3,435,541 13.39 46,001,894
PRLD Prelude Therapeutics Inc 2023-05-22 10,646,056 4.07 43,329,448
TERN Terns Pharmaceuticals Inc 2022-12-23 7,619,135 4.91 37,409,953
DMTX Dimension Therapeutics Inc 2015-10-27 5,397,698 5.95 32,116,303
CMPX Compass Therapeutics Inc 2022-11-08 18,791,422 1.45 27,247,562
IMRA Imara Inc 2021-07-16 4,199,068 6.32 26,538,110
SCPH scPharmaceuticals Inc 2022-11-25 5,559,528 4.49 24,962,281
AVBP ArriVent BioPharma Inc 2024-01-30 1,513,664 15.44 23,370,972
CALC CalciMedica Inc 2020-09-25 4,163,347 5.45 22,690,241
ICPT Intercept Pharmaceuticals Inc 2015-03-26 1,120,324 19.00 21,286,156
ACET Adicet Bio Inc 2024-01-25 11,447,140 1.68 19,231,195
ORIC ORIC Pharmaceuticals Inc 2021-03-30 2,212,571 8.07 17,855,448
ALPN Alpine Immune Sciences Inc 2023-12-28 264,315 64.56 17,064,176
ETNB 89bio Inc 2022-01-26 1,829,436 8.26 15,111,141
SIBN SI-BONE Inc 2018-10-19 985,368 14.57 14,356,812
CNST Constellation Pharmaceuticals Inc 2018-07-23 417,921 33.99 14,205,135
TELA TELA Bio Inc 2023-04-21 2,835,542 4.45 12,618,162
PMVP PMV Pharmaceuticals Inc 2023-11-22 6,475,291 1.75 11,331,759
JANX Janux Therapeutics Inc 2021-12-29 231,098 47.39 10,951,734
PASG Passage Bio Inc 2023-06-28 8,034,000 1.32 10,604,880
CRVS Corvus Pharmaceuticals Inc 2021-09-20 6,943,654 1.45 10,068,298
ALEC Alector Inc 2020-04-16 1,906,718 5.25 10,010,270
TSBX Turnstone Biologics Corp 2023-07-20 3,099,265 2.76 8,553,971
IRON Disc Medicine Inc 2023-12-18 224,405 27.55 6,182,358
ADAP Adaptimmune Therapeutics PLC 2018-06-06 4,901,310 1.08 5,268,908
DBTX Decibel Therapeutics Inc 2021-02-17 883,418 4.91 4,337,582
NXTC NextCure Inc 2019-05-13 2,711,013 1.35 3,659,868
ARQT Arcutis Biotherapeutics Inc 2022-06-24 415,142 8.47 3,516,253
XTNT Xtant Medical Holdings Inc 2018-02-14 3,316,128 0.95 3,150,322
SYRE Spyre Therapeutics Inc 2017-02-21 58,781 33.56 1,972,690
TORC resTORbio Inc 2018-01-30 690,055 2.28 1,573,325
RNAC Cartesian Therapeutics Inc 2016-06-27 60,847 21.03 1,279,612
KNTE Kinnate Biopharma Inc 2023-05-05 450,000 2.65 1,192,500
AFIB Acutus Medical Inc 2021-07-19 6,553,408 0.17 1,091,142
GLTO Galecto Inc 2023-08-15 1,510,375 0.70 1,064,512
ARPO Aerpio Pharmaceuticals Inc 2020-12-08 346,265 2.20 761,783
LOGC LogicBio Therapeutics Inc 2020-10-01 296,296 2.07 613,333
KALA Kala Bio Inc 2018-02-08 68,957 6.30 434,429
INSP Inspire Medical Systems Inc 2020-08-18 1,784 237.45 423,611
RPTX Repare Therapeutics Inc 2021-09-07 96,190 3.20 307,808
IKNA Ikena Oncology Inc 2021-03-30 130,924 1.30 170,201
SIENQ Sientra Inc 2015-10-12 178,500 0.10 17,832
OTIC Otonomy Inc 2015-11-30 1,850,094 0.01 15,726
PIRS Pieris Pharmaceuticals Inc 2018-04-30 486 11.72 5,696
VRAYQ ViewRay Inc 2018-08-20 69,617 0.00 1
LOGC Logic Devices Inc 2018-10-23 6,466,783 0.00 0
ATHXQ Athersys Inc 2011-04-26 0 0.00 0
ROKA Sorrento Tech Inc 2017-10-03 0 0.65 0
STDY SteadyMed Ltd 2018-08-30 0 4.73 0
GKOS Glaukos Corp 2018-03-06 0 99.48 0
TCDAQ Tricida Inc 2022-11-25 0 0.00 0

Holding Weightings of Orbimed Advisors Llc


Orbimed Advisors Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Orbimed Advisors Llc has made a total of 0 transactions in Synthorx Inc (THOR) over the past 5 years. The most-recent trade in Synthorx Inc is the acquisition of 1,363,636 shares on December 11, 2018, which cost Orbimed Advisors Llc around $15 Million.

According to the SEC Form 4 filings, Orbimed Advisors Llc has made a total of 1 transactions in Prevail Therapeutics Inc (PRVL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Prevail Therapeutics Inc is the acquisition of 882,352 shares on June 24, 2019, which cost Orbimed Advisors Llc around $15 Million.

According to the SEC Form 4 filings, Orbimed Advisors Llc has made a total of 6 transactions in SpringWorks Therapeutics Inc (SWTX) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in SpringWorks Therapeutics Inc is the sale of 153,897 shares on September 12, 2022, which brought Orbimed Advisors Llc around $5 Million.

More details on Orbimed Advisors Llc's insider transactions can be found in the Insider Trading History of Orbimed Advisors Llc table.

Insider Trading History of Orbimed Advisors Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Orbimed Advisors Llc Trading Performance

GuruFocus tracks the stock performance after each of Orbimed Advisors Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Orbimed Advisors Llc is 9.16%. GuruFocus also compares Orbimed Advisors Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Orbimed Advisors Llc within 3 months outperforms 64 times out of 117 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Orbimed Advisors Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Orbimed Advisors Llc

Average Return

-2.01%

Average return per transaction

Outperforming Transactions

36%

38 out of 106 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.27 9.16 1.87 -2.01 -9.46 -12.27
Relative Return to S&P 500(%) 2.75 6.56 -2.81 -12.47 -19.36 -23.48

Orbimed Advisors Llc Ownership Network

Ownership Network List of Orbimed Advisors Llc

No Data

Ownership Network Relation of Orbimed Advisors Llc


Orbimed Advisors Llc Owned Company Details

What does Arcutis Biotherapeutics Inc do?

Who are the key executives at Arcutis Biotherapeutics Inc?

Orbimed Advisors Llc is the director & 10 percent owner of Arcutis Biotherapeutics Inc. Other key executives at Arcutis Biotherapeutics Inc include director & 10 percent owner Patrick J Heron , SVP and Chief Business Officer Matthew Richard Moore , and director & President and CEO Todd Franklin Watanabe .

Arcutis Biotherapeutics Inc (ARQT) Insider Trades Summary

Over the past 18 months, Orbimed Advisors Llc made no insider transaction in Arcutis Biotherapeutics Inc (ARQT). Other recent insider transactions involving Arcutis Biotherapeutics Inc (ARQT) include a net sale of 30,155 shares made by Todd Franklin Watanabe , a net sale of 37,403 shares made by Howard G. Welgus , and a net sale of 10,594 shares made by Masaru Matsuda .

In summary, during the past 3 months, insiders sold 29,378 shares of Arcutis Biotherapeutics Inc (ARQT) in total and bought 21,052 shares, with a net sale of 8,326 shares. During the past 18 months, 104,916 shares of Arcutis Biotherapeutics Inc (ARQT) were sold and 102,515 shares were bought by its insiders, resulting in a net sale of 2,401 shares.

Arcutis Biotherapeutics Inc (ARQT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arcutis Biotherapeutics Inc Insider Transactions

No Available Data

Orbimed Advisors Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Orbimed Advisors Llc. You might contact Orbimed Advisors Llc via mailing address: 601 Lexington Avenue, 54th Floor, New York Ny 10022.

Discussions on Orbimed Advisors Llc

No discussions yet.